Shcherbik S - Search Results

1

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.

Shcherbik S, Pearce N, Kiseleva I, Larionova N, Rudenko L, Xu X, Wentworth DE, Bousse T. Shcherbik S, et al. J Virol Methods. 2016 Jan;227:33-9. doi: 10.1016/j.jviromet.2015.10.009. Epub 2015 Oct 28. J Virol Methods. 2016. PMID: 26519883 Free PMC article.

2

Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines.

Shcherbik SV, Pearce NC, Levine ML, Klimov AI, Villanueva JM, Bousse TL. Shcherbik SV, et al. PLoS One. 2014 Mar 19;9(3):e92580. doi: 10.1371/journal.pone.0092580. eCollection 2014. PLoS One. 2014. PMID: 24647786 Free PMC article.

3

Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.

Shcherbik S, Sergent SB, Davis WG, Shu B, Barnes J, Kiseleva I, Larionova N, Klimov A, Bousse T. Shcherbik S, et al. J Virol Methods. 2014 Jan;195:18-25. doi: 10.1016/j.jviromet.2013.09.003. Epub 2013 Sep 18. J Virol Methods. 2014. PMID: 24056261 Free PMC article.

4

Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.

Shcherbik S, Pearce N, Balish A, Jones J, Thor S, Davis CT, Pearce M, Tumpey T, Cureton D, Chen LM, Villanueva J, Bousse TL. Shcherbik S, et al. PLoS One. 2015 Sep 25;10(9):e0138951. doi: 10.1371/journal.pone.0138951. eCollection 2015. PLoS One. 2015. PMID: 26405798 Free PMC article.

5

Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.

Isakova-Sivak I, Korenkov D, Smolonogina T, Tretiak T, Donina S, Rekstin A, Naykhin A, Shcherbik S, Pearce N, Chen LM, Bousse T, Rudenko L. Isakova-Sivak I, et al. Among authors: shcherbik s. Virology. 2017 Jan;500:209-217. doi: 10.1016/j.virol.2016.10.027. Epub 2016 Nov 6. Virology. 2017. PMID: 27829176 Free PMC article.

6

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.

Rekstin A, Isakova-Sivak I, Petukhova G, Korenkov D, Losev I, Smolonogina T, Tretiak T, Donina S, Shcherbik S, Bousse T, Rudenko L. Rekstin A, et al. Among authors: shcherbik s. Biomed Res Int. 2017;2017:9359276. doi: 10.1155/2017/9359276. Epub 2017 Jan 22. Biomed Res Int. 2017. PMID: 28210631 Free PMC article.

7

Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.

Korenkov DA, Laurie KL, Reading PC, Carolan LA, Chan KF, Isakova-Sivak II, Smolonogina TA, Subbarao K, Barr IG, Villanueva J, Shcherbik S, Bousse T, Rudenko LG. Korenkov DA, et al. Among authors: shcherbik s. Infect Genet Evol. 2018 Oct;64:95-104. doi: 10.1016/j.meegid.2018.06.019. Epub 2018 Jun 19. Infect Genet Evol. 2018. PMID: 29929009 Free PMC article.

8

Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.

Shcherbik S, Carney P, Pearce N, Stevens J, Dugan VG, Wentworth DE, Bousse T. Shcherbik S, et al. Virology. 2018 Sep;522:65-72. doi: 10.1016/j.virol.2018.07.005. Epub 2018 Jul 12. Virology. 2018. PMID: 30014859 Free PMC article.

9

WITHDRAWN: Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.

Shcherbik S, Sergent SB, Davis WG, Shu B, Barnes J, Klimov A, Bousse T. Shcherbik S, et al. J Virol Methods. 2013 Jul 18:S0166-0934(13)00269-3. doi: 10.1016/j.jviromet.2013.07.015. Online ahead of print. J Virol Methods. 2013. PMID: 23872266

10

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells.

Shcherbik S, Pearce N, Carney P, Bazhenova E, Larionova N, Kiseleva I, Rudenko L, Kumar A, Goldsmith CS, Dugan V, Stevens J, Wentworth DE, Bousse T. Shcherbik S, et al. Vaccine X. 2019 Jun 19;2:100031. doi: 10.1016/j.jvacx.2019.100031. eCollection 2019 Aug 9. Vaccine X. 2019. PMID: 31384746 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page